Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 268

1.

Association of eosinophilic inflammation with FKBP51 expression in sputum cells in asthma.

Tajiri T, Matsumoto H, Niimi A, Ito I, Oguma T, Nakaji H, Inoue H, Iwata T, Nagasaki T, Kanemitsu Y, Petrova G, Mishima M.

PLoS One. 2013 Jun 6;8(6):e65284. doi: 10.1371/journal.pone.0065284. Print 2013.

2.
3.

Increased C-reactive protein is associated with airway wall thickness in steroid-naive asthma.

Hoshino M, Ohtawa J, Akitsu K.

Ann Allergy Asthma Immunol. 2014 Jul;113(1):37-41. doi: 10.1016/j.anai.2014.04.014. Epub 2014 May 10.

PMID:
24824230
4.

A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation.

Berlyne GS, Parameswaran K, Kamada D, Efthimiadis A, Hargreave FE.

J Allergy Clin Immunol. 2000 Oct;106(4):638-44.

PMID:
11031333
5.

Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children.

Piacentini GL, Bodini A, Costella S, Vicentini L, Mazzi P, Sperandio S, Boner AL.

Eur Respir J. 1999 Jun;13(6):1386-90.

6.

Effects of steroid therapy on inflammatory cell subtypes in asthma.

Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR.

Thorax. 2010 May;65(5):384-90. doi: 10.1136/thx.2009.126722. Epub 2009 Dec 8.

PMID:
19996343
7.

Can we predict sputum eosinophilia from clinical assessment in patients referred to an adult asthma clinic?

Yap E, Chua WM, Jayaram L, Zeng I, Vandal AC, Garrett J.

Intern Med J. 2013 Jan;43(1):46-52. doi: 10.1111/j.1445-5994.2011.02565.x.

PMID:
21790924
8.

The relationship between exhaled nitric oxide measured with an off-line method and airway reversible obstruction in Japanese adults with asthma.

Tsuburai T, Tsurikisawa N, Taniguchi M, Morita S, Ono E, Oshikata C, Ohtomo M, Maeda Y, Ikehara K, Akiyama K.

Allergol Int. 2007 Mar;56(1):37-43. Epub 2007 Jan 29. Erratum in: Allergol Int. 2007 Sep;56(3):317.

9.

Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma.

Lim S, Jatakanon A, Meah S, Oates T, Chung KF, Barnes PJ.

Thorax. 2000 Mar;55(3):184-8.

10.

Effect of inhaled steroid therapy on exhaled nitric oxide and bronchial responsiveness in children with asthma.

Nishio K, Odajima H, Motomura C, Nakao F, Nishima S.

J Asthma. 2006 Dec;43(10):739-43.

PMID:
17169825
11.

Comparison of exhaled nitric oxide measurement with conventional tests in steroid-naive asthma patients.

Zietkowski Z, Bodzenta-Lukaszyk A, Tomasiak MM, Skiepko R, Szmitkowski M.

J Investig Allergol Clin Immunol. 2006;16(4):239-46.

12.

Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.

Xu J, Jiang F, Nayeri F, Zetterström O.

Respir Med. 2007 Jul;101(7):1447-54. Epub 2007 Mar 26.

13.

Assessment of inhaled BDP-dose dependency of exhaled nitric oxide and local and serum eosinophilic markers in steroids-naive nonatopic asthmatics.

Dal Negro R, Micheletto C, Tognella S, Turco P, Rossetti A, Cantini L.

Allergy. 2003 Oct;58(10):1018-22.

14.
15.
16.

NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma.

Mattes J, Storm van's Gravesande K, Reining U, Alving K, Ihorst G, Henschen M, Kuehr J.

Eur Respir J. 1999 Jun;13(6):1391-5.

17.

Biomarker-based asthma phenotypes of corticosteroid response.

Cowan DC, Taylor DR, Peterson LE, Cowan JO, Palmay R, Williamson A, Hammel J, Erzurum SC, Hazen SL, Comhair SA.

J Allergy Clin Immunol. 2015 Apr;135(4):877-83.e1. doi: 10.1016/j.jaci.2014.10.026. Epub 2014 Dec 6.

18.

Prostaglandin E2 and cysteinyl leukotriene concentrations in sputum: association with asthma severity and eosinophilic inflammation.

Aggarwal S, Moodley YP, Thompson PJ, Misso NL.

Clin Exp Allergy. 2010 Jan;40(1):85-93. doi: 10.1111/j.1365-2222.2009.03386.x. Epub 2009 Nov 4.

PMID:
19895589
19.

Smoking attenuates the age-related decrease in IgE levels and maintains eosinophilic inflammation.

Nagasaki T, Matsumoto H, Nakaji H, Niimi A, Ito I, Oguma T, Muro S, Inoue H, Iwata T, Tajiri T, Kanemitsu Y, Mishima M.

Clin Exp Allergy. 2013 Jun;43(6):608-15. doi: 10.1111/cea.12073.

PMID:
23711122
20.

Characteristics of asthma resistant to moderate dose inhaled corticosteroid treatment on bronchial hyperresponsiveness.

Fujimoto K, Yamaguchi S, Urushibata K, Hanaoka M, Koizumi T, Honda T, Kubo K.

Intern Med. 2006;45(14):843-9. Epub 2006 Aug 15.

Supplemental Content

Support Center